Triple-negative breast cancer (TNBC) is a special molecular subtype of breast cancer, of which accounts for around 15% proportion, and marked by the absent expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) 1. Here, ESR1 is linked to triple-negative breast carcinoma.